NEWS

Latest in Stem Cell Research

  • In the attempt to find a possible cure for Alzheimer’s disease (AD), mesenchymal stem cells (MSCs) and their derived extracellular vesicles (EVs) are being investigated for therapeutic purposes thanks to their protective and anti‐inflammatory properties. The results from this study show that MSC‐EVs operate in dampening inflammation (that favors and accelerates the pathogenic process in […]

    Read more
  • Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery. Recently, mesenchymal stem cells (MSCs) harvested from umbilical cord blood have attracted significant attention in clinical trials for COVID-19 due to their immunomodulatory and […]

    Read more
  • A team of researchers at the Washington University School of Medicine in St. Louis have converted human stem cells into insulin-producing cells, controlling the blood sugar levels of laboratory mice. Within just nine months, the mice had been cured of diabetes, hinting that the procedure may be used in humans to cure diabetes. Published in […]

    Read more
  • Last March, scientists announced that Mr. Castillejo, then identified only as the “London Patient,” had been cured of H.I.V. after receiving a bone-marrow transplant for his lymphoma. The donor carried a mutation that impeded the ability of H.I.V. to enter cells, so the transplant essentially replaced Mr. Castillejo’s immune system with one resistant to the virus. The […]

    Read more
  • Preterm birth and its complications are the leading cause of neonatal death. The main underlying pathological mechanisms for preterm complications are disruption of the normal maturation processes within the target tissues, interrupted by premature birth. Cord blood, as a new and convenient source of stem cells, may provide new, promising options for preventing preterm complications. […]

    Read more
  • Benefits of cord blood transplantation include low rates of relapse and chronic graft-versus-host disease (GVHD). However, the use of cord blood is rapidly declining because of the high incidence of infections, severe acute GVHD, and transplant-related mortality. UM171, a haematopoietic stem cell self-renewal agonist, has been shown to expand cord blood stem cells and enhance […]

    Read more
  • Intravenous infusion of banked autologous and sibling umbilicalcord blood (CB) is being studied in children with acquired neu-rological conditions and has demonstrated safety and feasibilityin phase I/II studies. To provide access to this investigationalprocedure while efficacy trials are conducted, an expandedaccess program (EAP) was developed. More than 1,400 children have enrolled in the screening protocol […]

    Read more
  • A study released in STEM CELLS Translational Medicine provides compelling evidence of how an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele (MMC). The finding could lead to a new strategy for treating this debilitating birth defect that affects about 1 out of […]

    Read more
  • An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery at the Children’s Hospital of Fudan University in Shanghai; the stem cell was taken from umbilical cord blood. The baby girl, identified by the hospital as Ranbao, started to develop symptoms including cough, fever, swollen lymph node and […]

    Read more
  • The baby girl Zhao Jiaxin was the first child in China to receive a cord blood transplant as a cure for a genetic form of irritable bowel disease that is often lethal to newborns.   Born in early 2015, baby Zhao began suffering from diarrhea and fever when she was just 8 days old. These […]

    Read more
  • Epileptic seizures could be halted by injecting stem cells into the brain, scientists claim. Researchers have developed a new treatment, which involves converting skin cells into stem cells – which can turn into any type.  The converted stem cells, designed to dampen down the effects of seizures, are then implanted back into the brain. The […]

    Read more
  • An international study published in the journal Blood by researchers led by Dr. Elie Haddad, a pediatric immunologist and researcher at CHU Sainte-Justine and professor at Université de Montréal, highlights the urgent need to develop better treatment strategies for patients suffering from severe combined immune deficiency (SCID). This deficiency, better known as “bubble baby disease” […]

    Read more
1 2 3 6